Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Healthpeak Properties (DOC) stock in plain English

Free brief · no signupStart here
DOCPublished Nov 15, 2026
Healthpeak Properties Inc
Real Estate · REIT - Healthcare Facilities
Leases specialized lab facilities and outpatient medical buildings to biotechnology companies and hospital systems.
Assets:
Lab space footprintConcentrated in Boston, South San Francisco, and San Diego biotech hubs
Outpatient medical portfolioAffiliated directly with regional health systems and hospital campuses
Merged scaleExpanded its medical office holdings through an all-stock merger with Physicians Realty Trust
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

65
OPS ScoreOperating finances
Latest quote
-0.78%$19.19
$13.56B
35.3×
$3.07B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 15, 2026Quotes updated Nov 20, 04:00 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was DOC. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Healthpeak Properties (DOC) do?

Healthpeak Properties Inc (DOC) is a U.S.-listed company in Real Estate (REIT - Healthcare Facilities). What it does: Leases specialized lab facilities and outpatient medical buildings to biotechnology companies and hospital systems. Owns and leases lab spaces and outpatient medical clinics in major healthcare and research clusters across America. It is worth $13.56B on the market and sold $3.07B over the last year.

Market cap
$13.56B
P/E ratio
35.3×
Annual sales
$3.07B
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Brief updated
Nov 15, 2026

DOC’s flags, in plain English

Each flag is a number from Healthpeak Properties’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 15, 2026.

Earnings Jumping

Profits up 324% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.

Pays You to Hold

Pays a 6.24% dividend a year. The company pays part of its profit to shareholders in cash. A dividend can be cut, so it is not guaranteed.

Cheap on Cash Flow

Priced at 11.9 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.

Priced for Perfection

Priced at 35.3 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.

1 more green flag and 1 more risk note open with the free trial. Try it free for 7 days.

Questions about DOC

How big is Healthpeak Properties?

Healthpeak Properties’ market cap is $13.56B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $3.07B: what customers paid the company over the last year, before any costs.

What is DOC’s P/E ratio?

DOC’s P/E ratio is 35.3×. Investors pay about 35.3 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with DOC?

A slump in early-stage biotechnology venture funding has lowered tenant demand for life science laboratory leases. That is one risk on Healthpeak Properties’ card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Healthpeak Properties’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. DOC’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card